Bank Of Nova Scotia Alx Oncology Holdings Inc Transaction History
Bank Of Nova Scotia
- $42.5 Billion
- Q1 2025
A detailed history of Bank Of Nova Scotia transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Bank Of Nova Scotia holds 105,858 shares of ALXO stock, worth $63,514. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105,858
Previous 105,306
0.52%
Holding current value
$63,514
Previous $175,000
62.86%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALXO
# of Institutions
91Shares Held
35.3MCall Options Held
34KPut Options Held
36.9K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$5.82 Million6.44% of portfolio
-
Redmile Group, LLC San Francisco, CA3.64MShares$2.18 Million0.24% of portfolio
-
Tang Capital Management LLC San Diego, CA3.16MShares$1.89 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$1.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$1.1 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $24.4M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...